Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

Thursday’s Trading Day
64.51 +1.37 / +2.17%
As of Aug 27
Day’s Change
Friday’s Pre-Market   Switch to standard view »
63.75 -0.76 / -1.18%
 
Volume: 8.5K

Today’s Trading

Previous close63.14
Today’s open64.03
Day’s range63.00 - 64.60
Volume12,592,052
Average volume (3 months)9,393,909
Market cap$106.8B
Dividend yield3.16%
Data as of 08/27/2015

Growth & Valuation

Earnings growth (last year)-57.03%
Earnings growth (this year)+28.34%
Earnings growth (next 5 years)+14.10%
Revenue growth (last year)+6.23%
P/E ratio50.0
Price/Sales5.28
Price/Book58.93

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.79+1.32%
NVONovo Nordisk+0.79+1.43%
GSKGlaxoSmithKline+0.74+1.83%
CELGCelgene+3.81+3.20%
Data as of 08/27/2015

Financials

Next reporting dateOctober 30, 2015
EPS forecast (this quarter)$1.06
Annual revenue (last year)$20.0B
Annual profit (last year)$1.8B
Net profit margin8.89%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts

Partner Offers